France, Sept. 22 -- Orange announced that Orange Ventures has invested in Biolevate, a French health-tech start-up specializing in knowledge-driven automation to accelerate the path to market for drugs and other life sciences products. This investment, made as part of Biolevate's latest financing round, reflects Orange's commitment to support the French Tech ecosystem, helping high potential companies scale in strategic sectors. It also illustrates Orange's ambition, under its Trust the future strategy, to foster trusted digital solutions that combine innovation, security, responsible AI and operational value for business, especially in the healthcare and life sciences sectors. Through Orange Ventures, Orange supports high-growth companies ...